Kim Henriksen Selected Research

Acids

7/2014	A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
4/2011	A quantitative assay for lysosomal acidification rates in human osteoclasts.
1/2011	Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength.
10/2010	Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.
9/2008	Ion transporters involved in acidification of the resorption lacuna in osteoclasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim Henriksen Research Topics

Disease

25	Bone Resorption 12/2021 - 08/2003
18	Weight Loss (Weight Reduction) 02/2024 - 07/2014
18	Body Weight (Weight, Body) 02/2024 - 07/2013
15	Insulin Resistance 02/2024 - 07/2013
15	Type 2 Diabetes Mellitus (MODY) 02/2024 - 08/2009
14	Obesity 11/2023 - 07/2013
14	Osteopetrosis 03/2021 - 11/2005
11	Osteoporosis 09/2019 - 07/2004
7	Fibrosis (Cirrhosis) 12/2023 - 07/2010
7	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2013
6	Dementia (Dementias) 10/2020 - 01/2015
5	Disease Progression 11/2023 - 08/2013
5	Inflammation (Inflammations) 03/2019 - 12/2011
4	Osteoarthritis 09/2019 - 12/2011
3	Weight Gain 02/2024 - 05/2011
3	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2012
3	Pain (Aches) 01/2019 - 12/2011
3	Rheumatic Diseases (Rheumatism) 01/2019 - 04/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2021
2	Osteogenesis Imperfecta (Lobstein Disease) 01/2021 - 01/2019
2	Cognitive Dysfunction 10/2020 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2017
2	Brain Injuries (Brain Injury) 09/2019 - 11/2016
2	Necrosis 01/2019 - 01/2008
2	Hyperglycemia 01/2017 - 07/2014
2	Hepatitis C 12/2016 - 01/2012
2	Hypertrophy 01/2016 - 01/2012
2	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 07/2014
2	Glucose Intolerance 01/2016 - 07/2013
2	Wounds and Injuries (Trauma) 05/2013 - 03/2013
2	Neoplasms (Cancer) 03/2013 - 07/2006
2	Rheumatoid Arthritis 01/2012 - 04/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024

Drug/Important Bio-Agent (IBA)

30	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2006
27	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 03/2013
19	Islet Amyloid PolypeptideIBA 02/2024 - 09/2015
18	Calcitonin Receptors (Calcitonin Receptor)IBA 02/2024 - 09/2015
15	Insulin (Novolin)FDA Link 02/2024 - 08/2009
7	CalciumIBA 10/2016 - 09/2007
6	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2023 - 09/2015
6	Peptides (Polypeptides)IBA 01/2021 - 11/2010
6	Collagen Type I (Type I Collagen)IBA 01/2021 - 07/2006
6	Matrix Metalloproteinases (MMPs)IBA 10/2020 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2005
6	salmon calcitonin (Calcimar)FDA LinkGeneric 01/2019 - 11/2010
5	Blood Glucose (Blood Sugar)IBA 11/2023 - 08/2014
5	KBP-042IBA 12/2021 - 07/2014
5	CollagenIBA 01/2021 - 08/2003
5	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 02/2012
5	AcidsIBA 07/2014 - 09/2008
5	Chloride Channels (Chloride Channel)IBA 08/2013 - 07/2004
4	KBP-088IBA 01/2020 - 01/2016
4	EpitopesIBA 01/2019 - 07/2006
4	Adenosine Triphosphatases (ATPase)IBA 09/2012 - 10/2007
4	Cathepsin KIBA 11/2005 - 08/2003
3	semaglutideIBA 12/2023 - 01/2023
3	IncretinsIBA 09/2023 - 09/2015
3	KBP-089IBA 01/2021 - 01/2017
3	Liraglutide FDA Link 01/2021 - 11/2017
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021 - 01/2012
3	PPAR gammaIBA 03/2019 - 08/2009
3	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 01/2019 - 06/2010
3	balaglitazoneIBA 01/2017 - 05/2011
3	ChloridesIBA 08/2013 - 09/2008
3	AntiportersIBA 04/2011 - 09/2008
3	Tartrate-Resistant Acid PhosphataseIBA 06/2010 - 07/2006
2	Glucagon (Glukagon)FDA Link 02/2024 - 01/2021
2	Glucagon Receptors (Glucagon Receptor)IBA 12/2023 - 01/2023
2	endotrophinIBA 11/2023 - 01/2017
2	EnzymesIBA 01/2023 - 03/2013
2	LipidsIBA 01/2023 - 12/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 07/2014
2	CholesterolIBA 01/2020 - 03/2019
2	Collagen Type II (Type II Collagen)IBA 01/2019 - 01/2019
2	collagen type I trimeric cross-linked peptideIBA 01/2019 - 07/2006
2	Cysteine Proteinase InhibitorsIBA 01/2019 - 09/2012
2	Oncostatin MIBA 01/2019 - 01/2008
2	Matrix Metalloproteinase InhibitorsIBA 01/2019 - 09/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018 - 01/2007
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 11/2017 - 01/2016
2	CytokinesIBA 01/2017 - 08/2013
2	Pioglitazone (Actos)FDA Link 01/2017 - 05/2011
2	Complement C3 (C3 Complement)IBA 12/2016 - 01/2013
2	LeptinIBA 09/2015 - 07/2013
2	Hormones (Hormone)IBA 07/2015 - 01/2007
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 08/2013 - 09/2010
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2013 - 01/2012
2	diphyllinIBA 09/2012 - 10/2007
2	Protons (Proton)IBA 04/2011 - 09/2008
2	Macrophage Colony-Stimulating FactorIBA 04/2007 - 01/2006
1	Human Regular Insulin (Humulin)IBA 02/2024
1	nasIBA 12/2023
1	cotadutideIBA 12/2023
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 11/2023
1	empagliflozinIBA 01/2023
1	SodiumIBA 01/2023

Therapy/Procedure

21	Therapeutics 02/2024 - 05/2011
2	Ovariectomy (Oophorectomy) 07/2013 - 07/2004